PURE Bioscience, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Jan 2017 | — | $3.9M | $3.9M |
| Apr 2017 | — | $2.5M | $2.7M |
| Jul 2017 | — | $1.3M | $1.6M |
| Oct 2017 | — | $4.6M | $3.2M |
| Jan 2018 | — | $3.3M | $2.1M |
| Apr 2018 | — | $2.2M | $1.0M |
| Jul 2018 | — | $1.3M | $851.0K |
| Oct 2018 | — | $2.0M | $776.0K |
| Jan 2019 | — | $1.1M | $335.0K |
| Apr 2019 | — | $1.2M | $340.0K |
| Jul 2019 | — | $1.2M | $398.0K |
| Oct 2019 | — | $1.4M | $904.0K |
| Jan 2020 | — | $776.0K | $246.0K |
| Apr 2020 | — | $3.3M | $2.0M |
| Jul 2020 | — | $4.8M | $3.8M |
| Oct 2020 | — | $4.9M | $3.5M |
| Jan 2021 | — | $4.5M | $2.9M |
| Apr 2021 | — | $3.9M | $2.8M |
| Jul 2021 | — | $3.3M | $2.4M |
| Oct 2021 | — | $2.7M | $1.8M |
| Jan 2022 | — | $2.2M | $1.1M |
| Apr 2022 | — | $1.6M | $511.0K |
| Jul 2022 | — | $3.9M | $3.4M |
| Oct 2022 | — | $3.0M | $2.5M |
| Jan 2023 | — | $2.1M | $1.5M |
| Apr 2023 | — | $1.3M | $781.0K |
| Jul 2023 | — | $272.0K | $1.1M |
| Oct 2023 | — | $-383.0K | $1.4M |
| Jan 2024 | — | $-1.3M | $557.0K |
| Apr 2024 | — | $-2.1M | $442.0K |
| Jul 2024 | — | $-2.9M | $349.0K |
| Oct 2024 | — | $-3.5M | $346.0K |
| Jan 2025 | — | $-4.3M | $202.0K |
| Apr 2025 | — | $-4.8M | $540.0K |
| Jul 2025 | — | $-5.1M | $334.0K |
| Oct 2025 | — | $-5.5M | $434.0K |
| Jan 2026 | — | $-6.3M | $198.0K |
| Apr 2026 | — | $-5.8M | $983.0K |